CSMS #61683287

Food and Drug Administration (FDA) New and End-Dated Center for Drug Evaluation and Research (CDER) Product Code

· View this week in context on the trade timeline

Action requiredPGA UpdateMedium urgency
Share this messageLinkedInEmail
CSMS # 61683287 - Food and Drug Administration (FDA) New and End-Dated Center for Drug Evaluation and Research (CDER) Product Code U.S. Customs and Border Protection sent this bulletin at 08/06/2024 04:44 PM EDT CSMS # 61683287 - Food and Drug Administration (FDA) New and End-Dated Center for Drug Evaluation and Research (CDER) Product Code The Food and Drug Administration (FDA) will end-date the Center for Drug Evaluation and Research (CDER) product codes listed below on September 6, 2024. Product Code/Description 56C[][]73/Cephalexin Hydrochloride (Cephalosporins) 56E[][]21/Doxycycline Monohydrate (Tetracyclines) 60M[][]28/Naltrexone Hydrochloride (Analgesic, Narcotic) 64G[][]28/Estrogens Conjugated (Estrogen) The Food and Drug Administration (FDA) has created new Center for Drug Evaluation and Research (CDER) product codes listed below. The product codes are available immediately. Product Code/Description 58Q[][]06/Faricimab-svoa 61J[][]18/Inclisiran 61R[][]24/Sugammadex (Antidote) 64F[][]29/Roflumilast (Enzyme Inhibitor) Please send any questions or concerns to the email address for the Product Code Builder Feedback: PCBFeedback@fda.hhs.gov . For assistance with product code identification, the public may also refer to the FDA Product Code Builder .
Agencies affected
FDA

This week in context

This message came out the week of Aug. 3 to Aug. 9, 2024. See that week against the 90 days before it, with every CSMS message by subject and the trade actions behind them.

Trade timeline preview: the week of Aug. 3 to Aug. 9, 2024 highlighted against the 90 days beforeView this week in context on the trade timeline →